Navigation Links
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
Date:6/10/2009

Follicle Stimulating Hormone." June 30 4th Annual Biopharm Asia Conference Singapore Duu-Gong Wu, PhD, Executive Director, PharmaNet Consulting, will make a presentation entitled "Overview of Follow-on Biologics Regulatory and Scientific Issues in US." He will also lead a post conference workshop on July 1 on the topic of the FDA's approval process for biologics and biological products. 49th Annual Meeting of the Teratology Society Rio Grande, Puerto Rico Bengt Danielsson, MD, PhD, Vice President, PharmaNet Consulting, will present "Exaggerated Pharmacology Versus True Toxicity." Dr. Danielsson's presentation is part of the International Life Sciences Institute and the Health and Environmental Sciences Institute's (ILSI/HESI) symposium on Maternal Toxicity and its Impact on Study Design and Data Interpretation.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,400 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    E-mail: ahess@pharmanet.com


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
2. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
3. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
4. PharmaNet Development Group Agrees to be Acquired by JLL Partners
5. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
6. Plexus Awarded Development Contract With QIAGEN
7. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
8. Microbia, Inc. Names Alex Chu as Vice President of Process Development
9. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
10. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 In ... Services industry has experienced robust growth. The industry, ... products, industrial materials, energy resources and other goods, has ... rising government regulation. As a result, IBISWorld forecasts that ... 2.8% to reach $946.8 million over the five-year period, ...
(Date:3/2/2015)... , March 2, 2015 Analyzing ... experts have identified a new syndrome, shedding light ... research also provides important information to help caregivers ... eventually treating it. "This syndrome illuminates ... sort of master switch that controls many other ...
(Date:3/2/2015)... NEW YORK and VANCOUVER, British ... Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), a ... of cannabinoid based therapies, today announced that ... a company overview during a live webcast at ... TIME:  1:15pm ET LINK:   http://VirtualInvestorConferences.com > click ...
(Date:3/2/2015)... CORAL SPRINGS, Florida , March 2, 2015 ... products, science-based pharmaceuticals and healthy whole food nutrition ... for treatments of lifestyle related disorders such as ... illnesses and health concerns.  Nutraceutical and Biotech Companies ... RIBT ), Amira Nature Foods Ltd. (NYSE: ...
Breaking Biology Technology:Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 2New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 3New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 4InMed Pharmaceuticals to Present Investor Webcast March 5 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7
... YORK , June 11 The Champalimaud Foundation, ... that Dr. J. Anthony Movshon , Director of ... William T. Newsome , Investigator at The Howard Hughes ... , are the recipients of its 2010 Vision Award.  The ...
... Genomic Health, Inc. (Nasdaq: GHDX ) today announced the ... of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of ... cancer, suggesting a potential role for the Onco typ e ... pending further study. The company also announced the first presentation ...
... , June 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... will host a conference call and webcast on Monday, June 7th, 2010 ... discuss the Phase I/II head and neck cancer data being presented that day ... , , ...
Cached Biology Technology:Prestigious International Champalimaud Vision Award to US Scientists 2Prestigious International Champalimaud Vision Award to US Scientists 3Prestigious International Champalimaud Vision Award to US Scientists 4Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 9Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting 2Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting 3
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
(Date:2/5/2015)... Carolina , 5. Februar 2015 /PRNewswire/ ... als spezialisiertes Logistikunternehmen und hat eine neue ... klinische Logistikfirma (Clinical Logistics Organization – CLO) ... neuen Kampagne lautet First , mit ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... ISRAEL, August 9, 2010 Ben-Gurion University of the Negev ... Samuel and Paula Elkeles Prize for Outstanding Scientist in the ... the Shraga Segal Department of Microbiology and Immunology and vice ... of Health Sciences. He is also the Irving Sklar ...
... is available in German . , Spectroscopic techniques ... look inside materials. They exploit the interaction of light waves ... spectroscopy, researchers from Helmholtz-Zentrum Berlin fr Materialien und Energie (HZB) ... solvent so-called electron transfer. They can even make assertions ...
... of Case Western Reserve University School of Medicine, has ... Pioneer Award. One of 17 awardees to ... genetic effects, where the biological features and disease risk ... much on the genetics of ancestral generations as on ...
Cached Biology News:Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research 2Help from the dark side 2Case Western Reserve geneticist receives prestigious NIH Director's Pioneer Award 2
Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: New Recommended Storage: Long term: -20C; Short term: +4...
X box-binding protein 1...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
Biology Products: